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In a previous study (22) on the kinetic impairment of muscle Gln metabolism in response to dexamethasone (DEX) with aging, it was observed that muscle Gln synthetase activity increased earlier, whereas muscle Gln concentration decreased later in old rats than in adults. However, there are no data concerning the pool of Gln coming from net muscle protein breakdown or concerning the flow of Gln released by the muscle. Thus the aim of the present study was to characterize by a kinetic approach the various components involved in Gln homeostasis in muscle from adult and old glucocorticoidtreated rats.
MATERIALS AND METHODS
Animals and experimental design. Male Sprague-Dawley rats (n ϭ 143), supplied by Iffa Credo (a Charles River company in L'Arbresle, France), were 24 mo old (n ϭ 67) or 3 mo old (n ϭ 76). After their arrival in our animal facilities, the rats were maintained on a standard diet from UAR (A04; UAR, Epinay/Orges, France) containing 17% plant proteins, 3% fat, 59% carbohydrate, and 21% water, as well as fibers, vitamins, and minerals, and water ad libitum. The total caloric content of the diet was 2,900 kcal/kg. The animals were kept in a controlled environment (constant temperature 24°C, and a 12:12-h light-dark cycle). After 10 days of acclimatization in standard cages and 5 days in individual metabolic cages, the adult rats were divided into seven groups: A3 (n ϭ 8), A5 (n ϭ 15), A7 (n ϭ 13), A3 pair-fed (PF; n ϭ 8), A5PF (n ϭ 8) or A7PF (n ϭ 8), and one healthy control group fed ad libitum (AL; n ϭ 16). Elderly rats were also divided into seven groups: E3 (n ϭ 8), E5 (n ϭ 9), E7 (n ϭ 13), E3PF (n ϭ 8), E5PF (n ϭ 8), E7PF (n ϭ 7) and AL (n ϭ 14). Experimental groups A3 and E3, A5 and E5, A7 and E7 received 1.50 mg/kg body wt of a DEX solution (4 mg/ml) once a day by intraperitoneal injection for 3, 5, or 7 days, respectively. This synthetic steroid is more often used than corticosterone because of its greater affinity for glucocorticoid receptors (6) . The dose used (1.5 mg/kg) induces a severe catabolic state (23) and anorexia (1, 23) in adult rats, which makes the study in parallel pair-fed rats mandatory. Thus pair-fed control groups A3PF, A5PF, A7PF and E3PF, E5PF, E7PF were matched for food intake to DEX-treated groups (A3, A5, A7 and E3, E5, E7, respectively) and were injected with an isovolumic solution of 0.9% NaCl. The AL group received no treatment and were fed ad libitum throughout the study. These rats were killed on the same day as the rats from the A5PF and E5PF groups (day 5). For statistical analysis, healthy rats (AL) in each population were randomly assigned to two subgroups: A0 (n ϭ 9) and A0PF (n ϭ 7) in adults; E0 (n ϭ 7) and E0PF (n ϭ 7) in old rats. The experiment was conducted in three successive series, each series including a balanced number of each group and each subgroup. Because mortality appeared in the E7 group (see RESULTS) during the first series, numbers of rats in the A7 and E7 groups in the third series were adjusted to reach an adequate number of rats for analysis in these groups. Overall, there was no difference among results from the three series (data not shown); therefore, the data were pooled for analysis. Body weight and food intake were recorded daily from day 0 to day 7. Twenty-four hours after the last DEX or NaCl injection, the rats were anesthetized and killed by beheading. Animal care and experimentation complied with the rules of our institution, and two of our team (M.-P. Vasson and L. Cynober) are authorized by the French Ministry of Agriculture and Forestry to use animal models of stress.
Plasma Gln Concentrations
After the beheading of animals, mixed blood was collected from the jugular vein and carotid artery and was withdrawn in heparinized tubes to measure concentrations of free AAs. Blood was centrifuged (ϩ4°C, 4,500 g, 10 min), and the plasma was deproteinized with sulfosalicylic acid (50 mg/ml). The supernatant was stored at Ϫ80°C for no longer than 15 days before the plasma AA analysis, which was performed by ion exchange chromatography with an AA autoanalyzer (model 6300; Beckman, Palo Alto, CA). The results of our participation in ERNDIM (the European Quality Control Scheme) indicate the accuracy of our AA determinations, in particular for Gln. Results are expressed in micromoles per liter.
Muscle Determinations
Because of the small muscle mass in both adult and old rats, it was impossible to study the muscle Gln homeostasis (production, release, and concentration) in a single muscle. Consequently, two types of muscles [epitrochlearis and extensor digitorum longus (EDL)] were analyzed, because their fiber composition is roughly similar (i.e., rich in type II fibers).
Muscle Gln concentration. Left epitrochlearis muscles were removed, weighed, frozen in liquid nitrogen, and stored at Ϫ80°C. After grinding in trichloroacetic acid, muscle Gln concentrations were determined by ion exchange chromatography as described in Plasma Gln Concentrations.
Muscle Gln production: Gln synthetase activity. Muscles of the hindlimbs (EDL) were rapidly removed, weighed, frozen in liquid nitrogen, and used to measure Gln synthetase activity with a colorimetric method previously described (21) .
Net protein breakdown. Right epitrochlearis muscles were dissected intact for incubation. Net protein breakdown was measured according to Baracos and Goldberg (2) with minor differences. Briefly, muscles were preincubated flaccid (7) for 30 min in KrebsHenseleit buffer (in mM: 119 NaCl, 4.8 KCl, 25 NaHCO3, 1 CaCl2, 1.24 NaH2PO4, and 1.25 MgSO4, pH 7.4) supplemented with 5 mM glucose, 2 mM HEPES, and 100 U/l insulin (Novo Nordisk, Bagsvaerd, Denmark) and were saturated with a 95% O2-5% CO2 gas mixture. Muscles were then transferred into fresh medium of the same composition. Flaccid incubated muscles were removed from the medium after 120 min of incubation, and the medium was frozen in liquid nitrogen until tyrosine (Tyr) analysis. Because Tyr is neither synthesized nor degraded by muscle, the release of this AA from muscle into the incubation medium directly reflects the net protein breakdown (2). The incubation medium was deproteinized with sulfosalicylic acid (50 mg/ml), and Tyr concentration was determined fluorometrically by combination with nitrophenol (30) .
Net muscle Gln release. Right epitrochlearis muscles were incubated as we have described. The incubation medium was deproteinized with sulfosalicylic acid (50 mg/ml), and Gln concentration, which directly reflects the net muscle Gln release, was measured by ion exchange chromatography (see Plasma Gln Concentrations).
Statistical Analysis
Data are presented as means Ϯ SE. For parameters measured daily in live animals, an analysis of variance (ANOVA) with repeated measurement and with one factor (effect of treatment) was performed for the A7 and E7 groups. For parameters measured after the animals were killed, a two-way ANOVA followed by a Newman-Keuls test was performed in adult or old rats to discriminate among effects of DEX (D), duration of treatment (T), and their interaction (D ϫ T). Because the two-way ANOVA requires two groups of rats at each time (one treated group and one control group), healthy ad libitum-fed rats (i.e., AL group) were randomly assigned to two subgroups: A0 and A0PF in adults; E0 and E0PF in old rats. When the effect of duration of treatment was significant (P Ͻ 0.05), treated groups were compared with healthy control rats (AL). Thus A3, A5, A7 and E3, E5, E7 groups were compared with A0 and E0, respectively; A3PF, A5PF, A7PF and E3PF, E5PF and E7PF were compared with A0PF and E0PF, respectively. When the effect of DEX was significant (P Ͻ 0.05), treated groups (A3, A5, A7, E3, E5, and E7) were compared with control pair-fed rats (respectively, A3PF, A5PF, A7PF, E3PF, E5PF, and E7PF). In these cases, the specific effect of DEX was studied and the effect of anorexia discarded. Muscle Gln release was analyzed with a two-way ANOVA, with changes in muscle Gln concentration as analysis of covariate. A direct statistical comparison of values between adult and old rats could not be performed, because baseline values between these two populations were different for several parameters.
PCSM software (Deltasoft, Grenoble, France) was used. Values of P Ͻ 0.05 were considered as significant.
RESULTS

Characteristics of Animals
All the adult rats survived glucocorticoid treatment. In aged rats, overall mortality rate was 10.4% and concerned the E7 group. In this latter group, mortality rate was 54%; most died after 5 days of glucocorticoid treatment (n ϭ 1 at day 5, n ϭ 2 at day 6, and n ϭ 3 at day 7), except one who died at day 2. The final number of rats in the E7 group submitted to analysis was n ϭ 6.
DEX induced anorexia from day 3 in adult rats and from day 6 in old animals. In adult rats, food intake improved after day 4 ( Fig. 1) .
At the beginning of the experiment (day 0), body weights of adult and old rats were, respectively, 369 Ϯ 4 g (AL group: 354 Ϯ 4 g, pair-fed group: 364 Ϯ 3 g, and glucocorticoidtreated group: 379 Ϯ 7 g) and 690 Ϯ 12 g (AL group: 681 Ϯ 23 g, pair-fed group: 697 Ϯ 23 g, and glucocorticoid-treated group: 689 Ϯ 14 g). The daily rate of body weight change was 2.2 Ϯ 0.4 g for adult rats and Ϫ1.9 Ϯ 1.2 g for old rats belonging to the AL group. Both adult and old glucocorticoidtreated rats lost body weight ( Table 1) . Most of this effect was induced specifically by DEX (P Ͻ 0.05 between DEX-treated rats and pair-fed animals). 
Plasma Gln Concentration
Muscle Parameters
Muscle mass. An atrophy of EDL for 5 days of treatment by glucocorticoid was observed in adult treated rats (Table 2) . No similar change was noted in EDL from aged rats. In epitrochlearis, atrophy occurred in old rats owing to the specific catabolic effect of DEX after 7 days of treatment by glucocorticoids.
Muscle Gln concentrations. In epitrochlearis, Gln concentrations decreased from 3 and 5 days of treatment by glucocorticoids in adult and old rats, respectively (Fig. 2) .
Muscle Gln production: Gln synthetase activity. Gln synthetase in EDL increased from day 7 and day 3 in adults and old DEX-treated animals, respectively, compared with their respective pair-fed groups (Fig. 3) .
Net protein breakdown. Compared with their respective pair-fed controls, muscles from adult DEX-treated rats did not show any change in net protein breakdown. In old rats, tyrosine release was increased on day 7 (Fig. 4) .
These three muscle parameters were not modified over time in adult or old pair-fed rats.
Muscle Gln release. The rate of Gln release (in nmol⅐ g Ϫ1 ⅐min
Ϫ1
) from epitrochlearis increased from day 3 [significant effect of duration of treatment (T): P ϭ 0.031] in adult glucocorticoid-treated rats (A3: 26.1 Ϯ 3.9; A5: 30.9 Ϯ 5.1; A7: 29.6 Ϯ 6.4 vs. A0: 16.9 Ϯ 6.2), and in adult pair-fed rats Table 1 ) to discriminate among effects of D, T, and D ϫ T.
Comparison of means was carried out with the Newman-Keuls test; *P Ͻ 0.01 vs. healthy rats, †P Ͻ 0.05 vs. pair-fed controls. 
DISCUSSION
Glucocorticoid administration induces a severe stress. In this context, it is not surprising that long-term (i.e., 7 days) DEX administration induced a marked mortality rate in rats belonging to the E7 group, even though this was not expected when we started the experiments. Two reasons may explain this high mortality rate. First, it could be primarily related to the hypermetabolic state. This latter is assessed by the greater body weight loss in old glucocorticoid-treated rats compared with pair-fed controls, which have the same food intake. It can be hypothesized that animals who died were in hypermetabolic state. This may have been more important than in rats surviving glucocorticoid treatment; perhaps the rats who died were unable to compensate for this hypermetabolic state. Measurement of metabolic rate would have been necessary to support these hypotheses. Second, this greater hypermetabolic state and the associated DEX-induced mortality could result from the development of infection (because DEX is known to be immunosuppressive) and/or the inability of the old organisms to provide sufficient amounts of Gln, which is an important source of energy in particular for immune cells during infection (26) .
We have demonstrated that the kinetic response to DEX of components involved in muscle Gln homeostasis differs markedly in adult and old rats ( Table 3) . As previously shown (22) , muscle Gln concentration decreased later in old glucocorticoidtreated rats (day 5) than in adults (day 3). Our findings clearly show that two mechanisms were implicated: on the one hand, muscle Gln production (i.e., Gln synthetase activity and net protein breakdown), which increased earlier in old rats than in adults; on the other hand, muscle Gln release, which occurred later in old rats than in adults. This suggests a coordinated response to glucocorticoid treatment to maintain the muscle Gln concentration at a normal level for as long as possible. Except for Gln release, muscle parameters in pair-fed rats remained unchanged, suggesting that this response is specific to glucocorticoids and relatively independent of anorexia induced by DEX.
The major role of glucocorticoids as a regulator of Gln synthetase activity has been well demonstrated in adult and old rats by Verdier et al. (29) . Muscle Gln synthetase activity is stimulated earlier in old than in adult rats. These results are in line with those obtained previously by both ourselves (22) and others (20) . The alteration of muscle fiber composition during aging (involution of type II to type I fibers) (10) and the greater number of glucocorticoid receptors in type I fibers (9) could explain the greater sensitivity of Gln synthetase activity to glucocorticoids in old rats.
The second component that contributes to the appearance of free Gln in the muscle is net protein breakdown. However, physiologically the implication of this mechanism in muscle Gln homeostasis is not very significant because, according to Kuhn et al. (12) , only 13% of Gln in the total free pool arises from muscle proteolysis. The effects of glucocorticoids on protein turnover in muscles in models such as those used in the present study are controversial (31) , and perhaps we missed a significant increase in net protein breakdown in DEX-treated Muscle Gln concentration
Modifications for all parameters are shown vs. pair-fed treatment except muscle Gln release, which in adults is shown vs. day 0 treatment. ™Signifi-cantly decreased; šsignificantly increased; ➩ no significant change. muscles from adult rats. However, the important and relevant point is the comparison between muscles from adult and old rats, which were all treated in the same conditions. From this point of view, our results are in agreement with those observed in the same type of model by Dardevet et al. (5) . The increase in protein breakdown occurred only in old animals treated for 7 days by glucocorticoids and reached the values observed in adults at basal state.
Concerning muscle Gln release, this parameter is increased in adults in both glucocorticoid-treated and pair-fed rats, suggesting that the decrease in food intake induced by glucocorticoids is responsible for this phenomenon. In old DEX-treated rats, the increase in muscle Gln release did not result from the decrease in food intake but merely from the direct effect of DEX. Parry-Billings et al. (25) demonstrated that muscle Gln release was lower in healthy old rats than in adult rats. This result does not appear to be supported by the present study (muscle Gln release in nmol⅐g Ϫ1 ⅐min Ϫ1 , A0: 16.9 Ϯ 6.2; E0: 18.3 Ϯ 5.4). In our catabolic conditions, increase in muscle Gln release occurred later in old rats than in adults. These results suggest that affinity or number of Gln transporters could deteriorate during physiological aging but also during DEX treatment in old rats, possibly in relation to an age-related alteration in hormonal control (19) .
In conclusion, the simultaneous study of muscle Gln synthesis, net muscle protein breakdown, and muscle Gln release has for the first time provided new insights into the mechanisms possibly underlying muscle Gln alterations during aging, and it forms a coherent pattern. We have demonstrated in old glucocorticoid-treated rats that the muscle capacity to synthesize Gln occurred earlier in old rats (day 3) than in adults (day 7), whereas an increase in muscle Gln release occurred later in old rats (day 5) than in adults (day 3). The combination of these two phenomena during the first phase of stress response induced a preservation of muscle Gln concentration in old rats. During a later phase, depletion in plasma Gln occurred in old rats, whereas muscle Gln production and release increased. This depletion in plasma Gln is probably partly the result of decrease in food intake but may also suggest that consumingorgan requirements for this AA are increased.
The conventional view (26) of adaptation to stress is an increase in Gln release by muscles to support increased requirements by the liver, the kidneys, the intestine, and immune cells. As a consequence, muscle Gln synthesis is increased, but not sufficiently, and in turn, muscle free Gln drops, which may induce an increase in net muscle protein breakdown (11); however, this latter point is controversial (14) and not in line with results of the present study.
Our data suggest that the metabolic adaptation in response to a glucocorticoid may change during aging: muscle Gln synthesis is preserved in elderly glucocorticoid-treated rats, but interorgan flow of Gln, which is essential to maintain whole body homeostasis, seems to be altered. In particular, muscles from elderly DEX-treated rats exhibit a reduced ability to release Gln. Further studies are required to determine whether this alteration could be responsible for higher mortality in the E7 group, why this change of priority occurs, and what the consequences are in terms of central organ requirement in stressed, aged people.
